期刊文献+

干扰素-γ加强肿瘤坏死因子相关凋亡诱导配体抑制神经母细胞瘤细胞的作用 被引量:3

IFN-γ enhance the ability of the inhibition of TRAIL to neuroblastoma cell line
原文传递
导出
摘要 目的探讨肿瘤坏死因子相关凋亡诱导配体(TRAIL)对人神经母细胞瘤的作用及干扰素-γ(IFN-γ)对新型凋亡分子TRAIL抗瘤活性的影响,并探讨其影响机制。方法应用MTT分析和流式细胞仪研究TRAIL对人神经母细胞瘤细胞的抑制作用及IFN-γ对TRAIL抗瘤活性的影响。用RT-PCR方法检测IFN-γ作用48h后,Caspase-8-mRNA的表达。结果TRAIL(10,50,100μg/L)单独作用、IFN-γ(1000U/mL)单独作用后,对SY5Y细胞的增殖抑制率分别为(4·38±0·89)%、(3·54±1·66)%、(5·03±1·26)%、(5·33±2·06)%;凋亡率分別为(5·18±3·33)%、(5·26±3·64)%、(5·00±2·88)%、(8·14±7·35)%。IFN-γ(1000U/mL)与TRAIL(100μg/L)联合作用后,对SY5Y细胞的增殖抑制率为(41·22±7·09)%;凋亡率为(21·29±6·20)%。RT-PCR方法发现IFN-γ作用48h后Caspase-8-mRNA的表达明显上调。结论神经母细胞瘤细胞SH-SY5Y对TRAIL不敏感,IFN-γ可以明显提高TRAIL对神经母细胞瘤细胞的敏感性,其发生机制可能是通过IFN-γ上调Caspase-8-mRNA的表达而实现的。 Objective To explore the effect of TRAIL on neuroblastoma cell line and the influence of IFN-γ on the antitumor effects of TRAIL. Methods Use MTT and flow cytometric analysis to detect the antitumor effects of TRAIL and study the effects of IFN-γ on TRAIL in inhibiting human neuroblastoma cells. Results The rates of killing of TRAIL alone,IFN-γ alone and the combination of TRAIL and IFN-γ were ( 5.03 ± 1.26 ) %, ( 5. 33 ± 2. 06 ) %, ( 41.22 ± 7.09 ) %. IFN-γ could enhance the killing rate of TRAIL to the SYSY cells. FCM analysis suggested that IFN-γ enhanced the killing rate of TRAIL to the SYSY cells based on inhibiting apoptosis of SYSY cells. Conclusion SH-SYSY cells are not sensitive to TRAIL. IFN-γ can upregulate the apoptosis of SYSY induced by TRAIL.
出处 《中国实用儿科杂志》 CSCD 北大核心 2006年第6期457-459,共3页 Chinese Journal of Practical Pediatrics
基金 烟台市科学技术计划项目(2004221)
关键词 神经母细胞瘤 IFN-Γ 肿瘤坏死因子相关凋亡诱导配体Caspase-8 Neurohlastoma IFN-γ TRAIL Caspasc-8
  • 相关文献

参考文献8

  • 1Wiley SR,Schooley K,Smolak D,et al.Identification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3:673-682.
  • 2Pitti RM,Marsters SA,Ruppert S,et al.Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family[J].J Biol Chem,1996,271:12687-12690.
  • 3Yang X,Thiele CJ.Targeting the tumor necrosis factor-related apoptosis-inducing ligand path in neuroblastoma[J].Cancer Lett,2003,197 (1):137-143.
  • 4Muhlethaler-Mottet A,BourloudKB,AudersetK,et al.Drug-mediated sensitization to TRAIL-induced apoptosis in Caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and Caspase-dependent cleavage of XIAP,Bcl-xL and RIP[J].Oncogene,2004,23 (32):5415-5425.
  • 5Iolascon A,Borriello A,Giordani L,et al.Caspase-3 and caspase-8 deficiency in human neuroblastoma[J].Cancer Genet Cytogenet,2003,146(1):41-47.
  • 6Seol DW,Li J,Seol MH,et al.Signaling events triggered by tumoer necrosis factor-related apoptosis-inducing ligand (TRAIL):caspase-8 is required for TRAIL-induced apoptosis[J].Cancer Res,2001,61 (3):1138-1143.
  • 7Eggert A,Grotzer MA,Zuzak TJ,et al.Resistance to tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression[J].Cancer Res,2001,61 (4):1314-1319.
  • 8Ribas J,Gomez-Arbones X,Boix J.Caspase-8/10 are not mediating apoptosis in neuroblastoma cells treated with CDK inhibiting drugs[J].Eur J Parmacol,2005,524 (1):49-52.

同被引文献45

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部